HomeCompareFBSE vs JNJ

FBSE vs JNJ: Dividend Comparison 2026

FBSE yields 142.86% · JNJ yields 2.14%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 FBSE wins by $19.52M in total portfolio value
10 years
FBSE
FBSE
● Live price
142.86%
Share price
$1.40
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$19.55M
Annual income
$8,225,014.26
Full FBSE calculator →
JNJ
Johnson & Johnson
● Live price
2.14%
Share price
$242.49
Annual div
$5.20
5Y div CAGR
28%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$30.5K
Annual income
$4,749.88
Full JNJ calculator →

Portfolio growth — FBSE vs JNJ

📍 FBSE pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodFBSEJNJ
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, FBSE + JNJ cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
FBSE pays
JNJ pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

FBSE
Annual income on $10K today (after 15% tax)
$12,142.86/yr
After 10yr DRIP, annual income (after tax)
$6,991,262.12/yr
JNJ
Annual income on $10K today (after 15% tax)
$182.28/yr
After 10yr DRIP, annual income (after tax)
$4,037.40/yr
At 15% tax rate, FBSE beats the other by $6,987,224.72/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of FBSE + JNJ for your $10,000?

FBSE: 50%JNJ: 50%
100% JNJ50/50100% FBSE
Portfolio after 10yr
$9.79M
Annual income
$4,114,882.07/yr
Blended yield
42.03%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on JNJ right now

FBSE
No analyst data
Altman Z
19030.9
Piotroski
1/9
JNJ
Analyst Ratings
20
Buy
17
Hold
3
Sell
Consensus: Buy
Price Target
$228.73
-5.7% upside vs current
Range: $190.00 — $265.00
Altman Z
5.2
Piotroski
4/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

FBSE buys
0
JNJ buys
0
No recent congressional trades found for FBSE or JNJ in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricFBSEJNJ
Forward yield142.86%2.14%
Annual dividend / share$2.00$5.20
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR0%28%
Portfolio after 10y$19.55M$30.5K
Annual income after 10y$8,225,014.26$4,749.88
Total dividends collected$18.03M$15.6K
Payment frequencyquarterlyquarterly
SectorStockHealthcare

Year-by-year: FBSE vs JNJ ($10,000, DRIP)

YearFBSE PortfolioFBSE Income/yrJNJ PortfolioJNJ Income/yrGap
1← crossover$24,986$14,285.71$10,594$274.49+$14.4KFBSE
2$60,093$33,358.76$11,294$360.69+$48.8KFBSE
3$139,283$74,982.82$12,133$476.91+$127.2KFBSE
4$311,456$162,423.26$13,156$635.42+$298.3KFBSE
5$672,698$339,440.31$14,432$854.61+$658.3KFBSE
6$1,404,965$685,177.81$16,056$1,162.76+$1.39MFBSE
7$2,840,723$1,337,410.52$18,175$1,604.53+$2.82MFBSE
8$5,566,801$2,527,227.75$21,009$2,252.68+$5.55MFBSE
9$10,584,947$4,628,469.98$24,911$3,229.73+$10.56MFBSE
10$19,550,908$8,225,014.26$30,458$4,749.88+$19.52MFBSE

FBSE vs JNJ: Complete Analysis 2026

FBSEStock

Fastbase, Inc. operates as a data and web analytics SaaS company worldwide. Its SaaS solution generates leads reports containing company profiles, visitor interactions, key employee contact data, LinkedIn profile information, and email addresses. Its products include WebLeads tool is a Google Analytics add-on that provides information on web traffic, including web visitor tracking, qualified leads, google analytics, leads in real-time, and verified business contacts; Google Ads Click Identifier that discover who clicks on ads, as well as start google ads campaign and get leads sent directly to inbox daily; Google Business Ads that generate leads from Google Analytics; and MailAds that put ads in front of potential customer, track and identify ad visitors, and get lists of qualified leads. The company was founded in 2014 and is based in New York, New York.

Full FBSE Calculator →

JNJHealthcare

Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide, but strategically separated its Consumer Health business into Kenvue Inc. in 2023 to focus on its higher-growth, innovation-driven segments; the former Consumer Health brands (including TYLENOL, LISTERINE, and BAND-AID) are now owned by Kenvue. The company's core focus is now split between its Innovative Medicine (formerly Pharmaceutical) segment, which offers prescription products for complex diseases such as rheumatoid arthritis, various cancers, HIV/AIDS, and neurodegenerative disorders; and its MedTech (Medical Devices) segment, which provides advanced technology solutions including electrophysiology products, neurovascular care products, orthopaedics (hips, knees, spine), advanced surgery solutions, and disposable contact lenses under the ACUVUE brand. Company's two remaining segments primarily serve hospitals, healthcare professionals, wholesalers, and retailers, continuing its mission of advancing human health since its founding in 1886 and its current basing in New Brunswick, New Jersey.

Full JNJ Calculator →
📬

Get this FBSE vs JNJ comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

FBSE vs SCHDFBSE vs JEPIFBSE vs OFBSE vs KOFBSE vs MAINFBSE vs ABBVFBSE vs MRKFBSE vs PFE

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.